TRPV4-ANTAGONISTEN

European patent · EP3515887 · In force

Register entry

Publication number: EP3515887
Application number: EP17784400
Kind: European patent with effect for Switzerland and Liechtenstein
Status: In force
Specification: Granted
Filed: Sep 20, 2017
Published: Jul 31, 2019
Granted: Jul 7, 2021
Protection ends at the latest: Sep 19, 2037
Next annual fee due: Sep 30, 2027
IPC classes: C07D 207/48 (2006.01)
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
C07D 413/12 (2006.01)
C07D 498/10 (2006.01)
A61K 31/40 (2006.01)
A61K 31/4439 (2006.01)
A61K 31/41 (2006.01)
A61K 31/506 (2006.01)
A61P 9/00 (2006.01)
A61P 1/16 (2006.01)
A61P 11/00 (2006.01)
A61P 11/14 (2006.01)
A61P 13/10 (2006.01)
Priority: US 201662396991 P 20.09.2016
US 201762482296 P 06.04.2017
PCT application: PCT/IB2017/055700 20.09.2017
PCT publication: WO2018/055524 29.03.2018
Filing language: English
Source: Swissreg

What the Federal Institute of Intellectual Property published about this title, newest first.

Oct 1, 2026
Next annual fee due on
Next annual fee due on
30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
Dec 16, 2025
Corrected
Owner
GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom → GlaxoSmithKline Intellectual Property (No. 2) Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
Published in Swissreg on 16.12.2025
Nov 7, 2025
Holder’s address changed
Owner
GlaxoSmithKline Intellectual Property (No. 2), Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
Published in Swissreg on 07.11.2025
Oct 1, 2025
Next annual fee due on
Next annual fee due on
30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
Oct 3, 2024
Change
Published in Swissreg on 03.10.2024
Oct 1, 2023
Change
Published in Swissreg on 01.10.2023
Oct 1, 2022
Change
Published in Swissreg on 01.10.2022
May 18, 2022
Change
Published in Swissreg on 18.05.2022

2 earlier entries

Sep 21, 2021
Agent entered
Representative
AWA Switzerland Ltd., Case Postale 2243, 2800 Delémont 2
Published in Swissreg on 21.09.2021
Jul 7, 2021
Granted
Published in Swissreg on 07.07.2021

GlaxoSmithKline Intellectual Property (No. 2) Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage, SG1 2NY, GB

AWA Switzerland Ltd.

Case Postale 2243, 2800 Delémont 2